Late oncological occurrences following radical cystectomy in patients with bladder cancer

European Urology

Volumn 43, Issue 5, 2003, Pages 489-494

  Solsona, E ^a   Iborra, I ^a   Rubio, J ^a   Casanova, J ^a   Dumont, R ^a   Monros J L ^a  

^a INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

Author keywords

Bladder cancer; Cystectomy; Follow up schedule; Late oncological occurrences; Late recurrence

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYSTECTOMY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; INTRAVENOUS UROGRAPHY; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; TREATMENT OUTCOME; URINARY TRACT TUMOR; URINE CYTOLOGY; UROTHELIUM;

EID: 0038643541     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0302-2838(03)00100-3     Document Type: Article

References (22)

1. Sengelov L, Kamby C, von der Maase H. Metastatic urothelial cancer: evaluation of prognostic factors and change in prognosis during the last twenty years. Eur Urol 2001;39:634-42.
2. Steinberg GD, Trump DL, Cummings KB. Metastatic bladder cancer. Urol Clin North Am 1992;19:735-46.
3. Westney LO, Pisters LL, Pettaway CA, Tu S-M, Pollack A, Dinney CPN. Presentation, methods of diagnosis and therapy for pelvic recurrence following radical cystectomy for transitional cell carcinoma of the bladder. J Urol 1998;159:792-5.
4. Saxman SB, Propert KJ, Einhorn LH, Crawford ED, Tannock I, Raghavan D, et al. Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. J Clin Oncol 1997;15:2564-9.
5. Sternberg CN, Yagoda A, Scher HI, Watson RC, Geller N, Herr HW, et al. Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium: efficacy and patterns of response and relapse. Cancer 1989;64:2446-58.
6. International Collaboration of Trialists: Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer - a randomized controlled trial. Lancet 1999;354:533-41.
7. Smith JA, Crawford ED, Paradelo JC, Blumensttein B, Herschman BR, Grossman HB, et al. Treatment of advanced bladder cancer with combined preoperative irradiation and radical cystectomy versus cystectomy alone: a phase III intergroup study. J Urol 1997;157:805-7.
8. Balaji KC, McGuire M, Grotas J, Grimaldi G, Russo P. Upper tract recurrences following radical cystectomy: an analysis of prognostic factors, recurrence pattern and stage at presentation. J Urol 1999;162:1603-6.
9. Kenworthy P, Tanguay S, Dinney CPN. The risk of upper tract recurrence following cystectomy in patients with transitional cell carcinoma involving the distal ureter. J Urol 1996;155:501-3.
10. Alhering TA, Lievskosky G. Surgical treatment of urethral cancer in the male patients. In: Skinner DG, Lievskosky G, editors. Diagnosis and Management of Genitourinary Cancer. Philadelphia: Saunders; 1988. p. 627-36.
11. Beahrs JR, Fleming TR, Zincke H. Risk of local urethral recurrence after radical cystectomy for bladder cancer. J Urol 1984;131:264-6.
12. Sakai N, Yamada T, Asao T, Murayama T. A case of urethral recurrence found 15 years after radical cystectomy. Int J Urol 1999;11:578-80.
13. Stöckle M, Gökcebay E, Riedmiller H, Hohenfellner R. Urethral tumor recurrences after radical cystoprostatectomy: the case for primary cystoprostatourethrectomy? J Urol 1900;143:41-2.
14. Herr HW. Extravesical tumor relapse in patients with superficial bladder tumors. J Clin Oncol 1998;16:1099-102.
15. Solsona E, Iborra I, Ricós JV, Monrós JL, Dumont R, Almenar S. Extravesical involvement in patients with bladder carcinoma in situ: biological and therapy implications. J Urol 1996;155:895-9.
16. Braslis KG, Soloway MS. Management of uretheral and renal pelvic recurrence after cystectomy. Urol Clin North Am 1994;21:653-9.
17. Hardeman SW, Soloway MS. Urethral recurrence following radical cystectomy. J Urol 1990;144:666-9.
18. Dood PM, McCaffrey JA, Herr HW, Mazundar M, Bacik J, Higgins G, et al. Outcome of postchemotherapy surgery after treatment with methotrexate, vinblastine, doxorubicine and cisplatin in patients with unresectable or metastatic transitional cell carcinoma. J Clin Oncol 1999;17:2546-52.
19. Evans CP, Swanson DA. What to do if Lymph Nodes are positive? Semin Urol Oncol 1996;14:96-102.
20. Badalament RA, Bennet WF, Bova JG, Keworthy PR, Wise HA, Smith S, et al. Computed tomography of primary transitional cell carcinoma of upper urinary tracts. Urology 1992;40:71-5.
21. Leistenschneider W, Nagel R. Lavage cytology of the renal pelvis and ureter with special reference to tumors. J Urol 1980;124:598-600.
22. Schwartz EB, Bekirov H, Melman A. Urothelial tumors of upper tract following treatment of primary bladder transitional cell carcinoma. Urology 1992;40:509-11.